1. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity. (December 2017) Authors: Litton, J.; Scoggins, M.; Ramirez, D.; Murthy, R.; Whitman, G.; Hess, K.; Adrada, B.; Moulder, S.; Barcenas, C.; Valero, V.; Gomez, J.; Mittendorf, E.; Thompson, A.; Helgason, T.; Mills, G.; Piwnica-Worms, H.; Arun, B. Journal: NPJ breast cancer Issue: Volume 3(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A model using easily evaluated clinical features to identify triple negative breast cancer (TNBC) patients (pts) with high probability of achieving pathologic complete response (pCR) to neoadjuvant systemic therapy (NAST). (March 2019) Authors: Moulder, S.; Adrada, B.; Lim, B.; Ueno, N.; Candelaria, R.; Rauch, G.; Litton, J.; Thompson, A.; Huo, L.; Hess, K. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer-related internet use in patients with advanced cancer in a phase I clinical trials clinic. (December 2016) Authors: George, G.; Buford, A.; Hess, K.; Piha-Paul, S.; Zinner, R.; Subbiah, V.; Iwuanyanwu, E.; Cleeland, C.; Meric-Bernstam, F.; Bernstam, E.; Hong, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficient clinical research infrastructure and trial performance: Assessment of a dedicated clinical trials unit within an academic cancer center. (December 2016) Authors: Tang, C.; Hess, K.; Sanders, D.; Davis, S.; Kurzrock, R.; Lee, J.J.; Meric Bernstam, F.; Hong, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Electronic Structure Calculations Using An Adaptive Wavelet Basis. Issue 1 (1998) Authors: Richie, D. A.; von Allmen, P.; Hess, K.; Martin, Richard M. Journal: VLSI design Issue: Volume 8:Issue 1/4(1998) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First description of a local Coprinopsis cinerea skin and soft tissue infection. (January 2018) Authors: Correa-Martinez, C.; Brentrup, A.; Hess, K.; Becker, K.; Groll, A.H.; Schaumburg, F. Journal: New microbes and new infections Issue: Volume 21(2018) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gain Calculation in a Quantum Well Laser Simulator Using an Eight Band k.p Model. Issue 1 (1998) Authors: Oyafuso, F.; von Allmen, P.; Grupen, M.; Hess, K. Journal: VLSI design Issue: Volume 6:Issue 1/4(1998) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incidence of immune-related adverse events in patients who received immunotherapy and radiographic analysis to predict pneumonitis. (December 2016) Authors: Fujii, T.; Colen, R.; Bilen, M.; Hess, K.; Hajjar, J.; Suarez-Almazor, M.; Alshawa, A.; Hong, D.; Stephen, B.; Janku, F.; Subbiah, V.; Kato, S.; Karp, D.; Piha-Paul, S.; Tsimberidou, A.; Fu, S.; Sharma, P.; Meric-Bernstam, F.; Naing, A. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inclusion of Bandstructure and Many-Body Effects in a Quantum Well Laser Simulator. Issue 1 (1998) Authors: Oyafuso, F.; von Allmen, P.; Grupen, M.; Hess, K. Journal: VLSI design Issue: Volume 8:Issue 1/4(1998) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response. Issue 1 (December 2015) Authors: Liu, X.; George, G.; Tsimberidou, A.; Naing, A.; Wheler, J.; Kopetz, S.; Fu, S.; Piha-Paul, S.; Eng, C.; Falchook, G.; Janku, F.; Garrett, C.; Karp, D.; Kurzrock, R.; Zinner, R.; Raghav, K.; Subbiah, V.; Hess, K.; Meric-Bernstam, F.; Hong, D. Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗